| DC Field | Value | Language |
|---|
| dc.contributor.author | Burda, Y. E. | - |
| dc.contributor.author | Nadezhdin, S. V. | - |
| dc.contributor.author | Zubareva, E. V. | - |
| dc.contributor.author | Pokrovskii, M. V. | - |
| dc.contributor.author | Faitelson, A. V. | - |
| dc.date.accessioned | 2022-04-26T07:12:18Z | - |
| dc.date.available | 2022-04-26T07:12:18Z | - |
| dc.date.issued | 2016 | - |
| dc.identifier.citation | Test-system for estimation of activity of GSK-3 inhibitors as antihypoxants and differentiation of endothelial progenitors in vitro / Y.E. Burda [et al.] // Research Result: Pharmacology and Clinical Pharmacology. - 2016. - Vol. 2, № 1(2).- P. 58-62. - Doi: 10.18413/2313-8971-2016-2-1-58-62. - Refer.: p. 61-62. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46349 | - |
| dc.description.abstract | A model test-system was developed for validation in vitro of antihypoxic and endothelio-differentiating activity of newly created glycogen synthase kinase-3 inhibitors in comparison with the reference drug β4-thymosin | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | glycogen synthase kinase-3 | ru |
| dc.subject | GSK-3 | ru |
| dc.subject | β4-thymosin | ru |
| dc.subject | hypoxia | ru |
| dc.subject | ischemia | ru |
| dc.subject | endothelium | ru |
| dc.subject | GSK-3 inhibitors | ru |
| dc.title | Test-system for estimation of activity of GSK-3 inhibitors as antihypoxants and differentiation of endothelial progenitors in vitro | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 2, № 1
|
